| 前收盘价格 | 131.07 |
| 收盘价格 | 131.19 |
| 成交量 | 469,697 |
| 平均成交量 (3个月) | 1,484,887 |
| 市值 | 10,341,484,544 |
| 市盈率 (P/E TTM) | 14.19 |
| 预期市盈率 (P/E Forward) | 13.14 |
| 价格/销量 (P/S) | 1.76 |
| 股市价格/股市净资产 (P/B) | 1.42 |
| 52周波幅 | |
| 利润日期 | 22 Jul 2025 - 28 Jul 2025 |
| 营业毛利率 | 9.82% |
| 营业利益率 (TTM) | 12.83% |
| 稀释每股收益 (EPS TTM) | 9.71 |
| 季度收入增长率 (YOY) | -4.80% |
| 季度盈利增长率 (YOY) | 24.50% |
| 总债务/股东权益 (D/E MRQ) | 37.12% |
| 流动比率 (MRQ) | 1.29 |
| 营业现金流 (OCF TTM) | 1.16 B |
| 杠杆自由现金流 (LFCF TTM) | 901.28 M |
| 资产报酬率 (ROA TTM) | 4.35% |
| 股东权益报酬率 (ROE TTM) | 8.30% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | ICON plc | 看涨 | 看跌 |
AIStockmoo 评分
1.4
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.38 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.63% |
| 机构持股比例 | 92.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bluespruce Investments, Lp | 31 Dec 2024 | 1,223,117 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 240.00 (Evercore ISI Group, 84.42%) | 购买 |
| 240.00 (UBS, 84.42%) | 购买 | |
| 中 | 225.00 (72.89%) | |
| 低 | 180.00 (Barclays, 38.31%) | 保留 |
| 平均值 | 220.43 (69.38%) | |
| 总计 | 5 购买, 2 保留 | |
| 平均价格@调整类型 | 186.54 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 21 Aug 2025 | 200.00 (53.68%) | 保留 | 175.70 |
| Barclays | 25 Jul 2025 | 180.00 (38.31%) | 保留 | 187.01 |
| Evercore ISI Group | 25 Jul 2025 | 240.00 (84.42%) | 购买 | 187.01 |
| 09 Jul 2025 | 170.00 (30.63%) | 购买 | 150.53 | |
| Mizuho | 25 Jul 2025 | 225.00 (72.89%) | 购买 | 187.01 |
| Truist Securities | 25 Jul 2025 | 234.00 (79.81%) | 购买 | 187.01 |
| UBS | 25 Jul 2025 | 240.00 (84.42%) | 购买 | 187.01 |
| Baird | 24 Jul 2025 | 224.00 (72.12%) | 购买 | 195.01 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合